ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,153Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 134

$840K Total Retail Price of All Prescriptions

Rank: 10 out of 134

454 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,212 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$103 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LEVOTHYROXINE SODIUM 424 368 1 1
WARFARIN SODIUM 359 339 2 8
SIMVASTATIN 322 289 3 2
OMEPRAZOLE 204 197 4 3
METFORMIN HCL 180 147 5 9
ZOLPIDEM TARTRATE 176 150 6 15
LISINOPRIL 171 143 7 4
METOPROLOL SUCCINATE 165 148 8 16
HYDROCHLOROTHIAZIDE 163 159 9 13
HYDROCODONE-ACETAMINOPHEN 159 141 S3 10 5
FUROSEMIDE 157 144 11 7
LOSARTAN POTASSIUM 152 149 12 11
AMLODIPINE BESYLATE 149 145 13 6
FLUTICASONE PROPIONATE 128 112 14 34
METOPROLOL TARTRATE 124 105 15 17
CITALOPRAM HBR 114 107 16 14
MELOXICAM 113 110 17 35
POTASSIUM CHLORIDE 109 103 18 10
TRAZODONE HCL 105 97 19 23
TAMSULOSIN HCL 102 102 20 26
TRAMADOL HCL 93 73 21 22
GABAPENTIN 93 71 21 12
LOSARTAN-HYDROCHLOROTHIAZIDE 88 74 23 50
ADVAIR DISKUS 87 79 24 38
DONEPEZIL HCL 84 84 25 30
SPIRIVA 79 66 26 47
CARVEDILOL 78 77 27 27
NAMENDA 78 78 27 53
PANTOPRAZOLE SODIUM 76 57 29 57
ALLOPURINOL 70 69 30 25
AMITRIPTYLINE HCL 70 54 R 30 51
ATORVASTATIN CALCIUM 67 63 32 18
PROAIR HFA 67 49 32 49
PAROXETINE HCL 64 64 34 46
SPIRONOLACTONE 62 56 35 29
CLONIDINE HCL 60 57 36 60
ALENDRONATE SODIUM 59 52 37 21
BUPROPION XL 58 41 38 108
RAMIPRIL 53 53 39 73
PREDNISONE 51 38 40 28
LANTUS SOLOSTAR 50 46 41 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.